Physician profile
Scott A Koss
NPI 1265427876
$29,211.59
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $853 · 2020: $1,125 · 2021: $7,574 · 2022: $2,905 · 2023: $8,968 · 2024: $7,788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $5,055 · Food and Beverage: $998 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,687.50 |
| Travel and Lodging | $5,055.43 |
| Food and Beverage | $997.65 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $22,158.55 | 2021-2024 | Stabilit System, Stabilit, Star Tumor Ablation System |
| Relievant Medsystems, INC. | $2,224.06 | 2022-2023 | Intracept |
| Genesys Orthopedics Systems, L.L.C. | $1,891.06 | 2023 | Sacroiliac Joint Fusion System |
| Medtronic Vascular, INC. | $1,367.48 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $803.85 | 2023 | Iovera |
| Medical Device Business Services, INC. | $453.98 | 2019 | |
| Sirtex Medical INC | $141.13 | 2019 | |
| Abbott Laboratories | $123.90 | 2024 | 2nd Gen Centrimag Primary Console |
| Medtronic, INC. | $18.68 | 2022 | |
| Argon Medical Devices, INC. | $15.12 | 2019 | |
| Boston Scientific Corporation | $13.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Koss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.